Cholesterol depletion reduces aggregation of amyloid-beta peptide in hippocampal neurons

Neurobiol Dis. 2006 Sep;23(3):573-7. doi: 10.1016/j.nbd.2006.04.015. Epub 2006 Jun 14.

Abstract

A key event in the pathogenesis of Alzheimer's disease is the conversion of soluble amyloid Abeta-peptide into toxic aggregates. Here, we studied the effect of cholesterol depletion on the formation of insoluble Abeta. We found that reduction of neuronal cholesterol by approximately 25% reduced the neuronal formation of insoluble Abeta without affecting the secretion of soluble Abeta. Moreover, we demonstrate that Abeta-oligomers from Alzheimer's disease brains associate with a detergent-resistant membrane fraction in a cholesterol-dependent manner. These results suggest a key role for cholesterol in aggregation of Abeta.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / physiopathology
  • Alzheimer Disease / therapy
  • Amyloid beta-Peptides / metabolism*
  • Animals
  • Cell Membrane / metabolism
  • Cells, Cultured
  • Cholesterol / deficiency*
  • Down-Regulation / physiology
  • Hippocampus / metabolism*
  • Hippocampus / pathology
  • Hippocampus / physiopathology
  • Humans
  • Membrane Lipids / metabolism
  • Membrane Microdomains / metabolism*
  • Mice
  • Middle Aged
  • Neurons / metabolism*
  • Neurons / pathology
  • Plaque, Amyloid / metabolism
  • Plaque, Amyloid / pathology

Substances

  • Amyloid beta-Peptides
  • Membrane Lipids
  • Cholesterol